Robust evidence suggests that Lp(a) is a highly anticipated emerging target for intervention, increasing cardiovascular risk by promoting atherosclerosis and inflammation
10.1038/ijo.2009.10 36 GrillH
The differences between GLP-1 drugs include dosages (with weight loss typically requiring higher doses than diabetes management), the method of administration (most are injectable, but one is available in pill form), additional benefits (some may offer heart protection), age suitability (all are approved for adults, but some are also approved for children), and tolerance (if one GLP-1 drug is not well-tolerated, another may be tried)
In the UK, winter is a common turning point
Insulin acts like a key that opens tiny locks on the surface of muscle and fat cells, allowing glucose to move from the bloodstream into the cells where it can be used for energy